← Open Payments lookup

SARAH SANKEY: Open Payments

NPI 1710521687 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$480 in 26 payments from 15 companies in 2025. Trend: 2023 $922 · 2024 $604 · 2025 $480

Food & beverage: $480
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$77
Verona Pharma, Inc.3$56
Medtronic, Inc.2$55
Insmed, Inc.2$51
GENZYME CORPORATION3$45
Takeda Pharmaceuticals U.S.A., Inc.2$39
Grifols USA, LLC1$23
GlaxoSmithKline, LLC.1$21
Edwards Lifesciences Corporation1$20
Avadel CNS Pharmaceuticals, LLC1$18

Products named: FASENRA, DUPIXENT, Ohtuvayre, ILLUMISITE, Arikayce, Prolastin-C Liquid, TRELEGY ELLIPTA, ARALAST.

Industry payments across NE — which companies pay providers there.